|
시장보고서
상품코드
2075928
발기부전 치료 시장 : 약제별, 투여 경로별, 유통 채널별, 지역별Erectile Dysfunction Treatment Market, By Drugs, By Route of Administration, By Distribution Channel, By Geography |
||||||
발기부전 치료 시장은 2026년에 56억 7,000만 달러 규모에 이를 것으로 추정되며, 2033년까지 95억 9,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR 7.8%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 56억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) : | 7.80% | 시장 규모 예측(2033년) : | 95억 9,000만 달러 |
발기부전이란 성관계 중에 충분한 발기를 유지할 수 없는 상태를 말합니다. 이는 신체적 또는 심리적 상태의 징후입니다. 발기부전은 스트레스, 노화, 우울증, 당뇨병, 혈압 문제, 혹은 건강에 해로운 생활 습관으로 인해 발생합니다. 발기부전에는 약물 요법, 주사, 외용 크림 등 다양한 치료법이 있습니다. 시장에 진출한 기업들은 최소한의 시간 내에 효과적인 결과를 얻을 수 있는 의약품을 개발하기 위해 연구 개발 활동에 주력하고 있습니다. 비아그라는 발기부전 치료제로서 가장 널리 사용되는 약제 중 하나입니다. 많은 기업들이 제네릭 의약품에 대한 규제 당국의 승인을 얻기 위해 노력하고 있으며, 이것이 발기부전 치료 시장의 성장을 견인하고 있습니다. 예를 들어, 2017년 12월에는 고품질 제네릭 의약품을 제조하는 제약회사인 테바 파마슈티컬스가 바이아그라 제네릭 의약품에 대해 미국 식품의약국(US FDA)의 승인을 획득했습니다. 또한, 2018년 10월에는 발데나필의 또 다른 제네릭 의약품이 미국 FDA의 승인을 받았습니다. 발데나필은 포스포디에스테라제(PDE) 억제제라고 불리는 유형의 의약품으로, 음경 조직으로의 혈류를 증가시켜 발기를 촉진하는 작용을 합니다.
시장 역학
시장에 진출한 각 기업은 효과적이고 효율적인 결과를 얻기 위해 발기부전에 대한 첨단 치료법 제공에 힘쓰고 있습니다. 이에 따라 예측 기간 동안 세계 발기부전 치료 시장의 성장이 가속화될 것으로 전망됩니다. 예를 들어, 2019년 1월 25일 미국 국립생물공학정보센터(NCBI)가 발표한 기사에 따르면, 발기부전 치료에는 음경 보형물, 진공 보조 발기 장치, 요도 내 좌약과 같은 첨단 치료법 외에도 줄기세포 치료, 음경 외부 보형물, 다혈소판 혈장(PRP), 음경 충격파 요법과 같은 새로운 치료법도 이용 가능하며, 이러한 방법들은 남성의 발기부전 완화에 기여하고 있습니다.
발기부전 치료 및 관리에 대한 인식이 높아짐에 따라, 예측 기간 동안 전 세계 발기부전 치료 시장의 성장이 가속화될 것으로 전망됩니다. 예를 들어, 2021년 2월 12일에는 성 건강에 대한 인식을 높이기 위해 '성·생식 건강 인식 제고의 날'이 거행되었습니다. 이 사업은 캐나다 정부에 의해 시작되어, 이후 전 세계로 확산되었습니다. 전 세계적으로 발기부전 유병률이 증가하는 가운데, 이 사업은 사회 및 교육적으로 소외된 계층에게 정보를 제공하여 발기부전으로 인한 심각한 문제를 미연에 방지하는 것을 목적으로 하고 있습니다.
이 프로그램은 캐나다 정부에 의해 시작되었으며, 이후 전 세계로 확산되었습니다.
본 조사의 주요 특징 :
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 세계 발기부전 치료 시장의 주요 기업 프로파일을 작성하고 있습니다. 구체적으로는 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 발전 및 전략, 그리고 향후 계획입니다.
- 본 보고서에서 도출된 인사이트은 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 관해 충분한 정보를 바탕으로 의사결정을 내릴 수 있도록 해줍니다.
- 이 책 '세계의 발기부전 치료 시장 보고서'는 투자자, 공급업체, 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 발기부전 치료 시장을 분석하는 데 사용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적 및 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 발기부전 치료 시장 : 약물별(2021-2033년)
제5장 세계의 발기부전 치료 시장 : 투여 경로별(2021-2033년)
제6장 세계의 발기부전 치료 시장 : 유통 채널별(2021-2033년)
제7장 세계의 발기부전 치료 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
AJY 26.07.09Erectile Dysfunction Treatment Market is estimated to be valued at USD 5.67 Bn in 2026 and is expected to reach USD 9.59 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.67 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.80% | 2033 Value Projection: | USD 9.59 Bn |
Erectile dysfunction is the inability to maintain a firm erection during sexual activity. It is a sign of a physical or psychological condition. Erectile dysfunction is caused by stress, age, depression, diabetes, Blood pressure issues or an unhealthy lifestyle. Various treatments are available for erectile dysfunction such as drugs, injections, and topical creams. Market players are indulged in research and development activities for developing drugs for effective results with minimum time consumption. Viagra is one of the most used drugs for erectile dysfunction. Many companies are engaged to receive approval from regulatory authorities for generic medicines which drives the growth of erectile dysfunction treatment market. For instance, in December 2017, Teva Pharmaceuticals which is pharmaceutical manufacturer of high quality generic medicines has received the U.S. Food and Drug Administration (U.S.FDA) approval of generic medicine for Viagra and another generic version of Vardenafil was approved by the U.S.FDA in October 2018.Vardenafill is class of medicine called Phosphodiesterase (PDE) inhibitors which helps in increasing the blood flow to penile tissue to cause erection.
Market Dynamics
Market players are engaged in providing advanced treatments for erectile dysfunction for effective and efficient results. This is expected to increase the growth of the global erectile dysfunction treatment market over the forecast period. For instance, an article published on January 25, 2019 by the National Center for Biotechnology Information (NCBI) states that advanced treatments are available for erectile dysfunction treatment such as penile prosthesis, vacuum-assisted erectile, intraurethral suppository, along with novel therapies such as stem cell therapy, external penile prosthesis, platelet-rich plasma, and penile shockwave therapy, which help to reduce erectile dysfunction in men.
Increasing awareness for the treatment as well as management of erectile dysfunction is expected to increase the growth of the global erectile dysfunction treatment market over the forecast period. For instance, on February 12, 2021, Sexual and Reproductive Health Awareness day was celebrated to raise the awareness for sexual health awareness. This program was started by Canadian government, and it has since spread around the globe. This program aims to provide information to socially and educationally backward population to avoid the serious issues cause due to erectile dysfunction as the prevalence of erectile dysfunction is increasing globally.
This programme was started by the Canadian government, and it has since spread around the world.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global erectile dysfunction treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Boston Scientific, Mylan Pharmaceuticals Inc., Cipla Ltd., Pfizer Inc, Coloplast CORP, Eli Lily & Co, Gust Inc., Altera, Promedon , Dr. Reddys Laboratories Ltd., Zephyr Surgical Implants, Pos-T-Vac Inc., Bayer Pharma AG, Reflexonic Llc., Dong-A Pharmaceutical Co. Ltd., Owen Mumford Ltd., Vacurect Manufacturing Ltd., and
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global erectile dysfunction treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global erectile dysfunction treatment market
Detailed Segmentation:
- Global Erectile Dysfunction Treatment Market, By Drugs (Revenue, USD Bn, 2021 - 2033)
- Sildenafil (Viagra)
- Vardenafil (Levitra Staxyn)
- Tadalafil (Cialis)
- Avanafil (Stendra)
- Udenafil (Zydena)
- Others
- Global Erectile Dysfunction Treatment Market, By Route of Administration (Revenue, USD Bn, 2021 - 2033)
- Oral drugs
- Injections
- Topical application
- Global Erectile Dysfunction Treatment Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospitals Pharmacies
- Offline Pharmacies
- Online Pharmacies
- Global Erectile Dysfunction Treatment Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- By Drugs:
- Sildenafil (Viagra)
- Vardenafil (Levitra Staxyn)
- Tadalafil (Cialis)
- Avanafil (Stendra)
- Udenafil (Zydena)
- Others
- By Route of Administration:
- Oral drugs
- Injections
- Topical application
- By Distribution Channel:
- Hospitals Pharmacies
- Offline Pharmacies
- Online Pharmacies
- By Country:
- U.S.
- Canada
- By Drugs:
- Latin America
- By Drugs:
- Sildenafil (Viagra)
- Vardenafil (Levitra Staxyn)
- Tadalafil (Cialis)
- Avanafil (Stendra)
- Udenafil (Zydena)
- Others
- By Route of Administration:
- Oral drugs
- Injections
- Topical application
- By Distribution Channel:
- Hospitals Pharmacies
- Offline Pharmacies
- Online Pharmacies
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Drugs:
- Europe
- By Drugs:
- Sildenafil (Viagra)
- Vardenafil (Levitra Staxyn)
- Tadalafil (Cialis)
- Avanafil (Stendra)
- Udenafil (Zydena)
- Others
- By Route of Administration:
- Oral drugs
- Injections
- Topical application
- By Distribution Channel:
- Hospitals Pharmacies
- Offline Pharmacies
- Online Pharmacies
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Drugs:
- Asia Pacific
- By Drugs:
- Sildenafil (Viagra)
- Vardenafil (Levitra Staxyn)
- Tadalafil (Cialis)
- Avanafil (Stendra)
- Udenafil (Zydena)
- Others
- By Route of Administration:
- Oral drugs
- Injections
- Topical application
- By Distribution Channel:
- Hospitals Pharmacies
- Offline Pharmacies
- Online Pharmacies
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Drugs:
- Middle East
- By Drugs:
- Sildenafil (Viagra)
- Vardenafil (Levitra Staxyn)
- Tadalafil (Cialis)
- Avanafil (Stendra)
- Udenafil (Zydena)
- Others
- By Route of Administration:
- Oral drugs
- Injections
- Topical application
- By Distribution Channel:
- Hospitals Pharmacies
- Offline Pharmacies
- Online Pharmacies
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Drugs:
- Africa
- By Drugs:
- Sildenafil (Viagra)
- Vardenafil (Levitra Staxyn)
- Tadalafil (Cialis)
- Avanafil (Stendra)
- Udenafil (Zydena)
- Others
- By Route of Administration:
- Oral drugs
- Injections
- Topical application
- By Distribution Channel:
- Hospitals Pharmacies
- Offline Pharmacies
- Online Pharmacies
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Drugs:
- Company Profiles
- Boston Scientific *
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Mylan Pharmaceuticals Inc.
- Cipla Ltd
- Pfizer Inc.
- Coloplast CORP
- Eli Lily & Co,
- Gust Inc.
- Altera
- Promedon
- Reddys Laboratories Ltd
- Zephyr Surgical Implants
- Pos-T-Vac Inc.
- Bayer Pharma AG
- Reflexonic Llc.
- Dong-A Pharmaceutical Co. Ltd.
- Owen Mumford Ltd
- Vacurect Manufacturing Ltd
- Silimed
"*" marked represents similar segmentation in other categories in the respective section
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drugs
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Erectile Dysfunction Treatment Market, By Drugs, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Sildenafil (Viagra)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Vardenafil (Levitra Staxyn)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Tadalafil (Cialis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Avanafil (Stendra)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Udenafil (Zydena)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
5. Global Erectile Dysfunction Treatment Market, By Route of Administration, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Topical Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
6. Global Erectile Dysfunction Treatment Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
7. Global Erectile Dysfunction Treatment Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Mangoceuticals, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Futura Medical
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- CURE Pharmaceutical Holding Corp
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Glenmark Pharmaceuticals Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Mylan Pharmaceuticals Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Boston Scientific
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Cipla Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Pfizer Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Coloplast CORP
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Eli Lily & Co
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Gust Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Altera
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Promedon
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Dr. Reddys Laboratories Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bayer Pharma AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Reflexonic LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Mangoceuticals, Inc.
9. Section
- References
- Research Methodology
- About Us and Sales Contact
